Diagnostics (Jan 2023)

ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study

  • Mohamed El Sayed,
  • Pieter G. Postema,
  • Mareen Datema,
  • Laura van Dussen,
  • Jan A. Kors,
  • Cato C. ter Haar,
  • Hidde Bleijendaal,
  • Henrike Galenkamp,
  • Bert-Jan H. van den Born,
  • Carla E. M. Hollak,
  • Mirjam Langeveld

DOI
https://doi.org/10.3390/diagnostics13030354
Journal volume & issue
Vol. 13, no. 3
p. 354

Abstract

Read online

Background: Fabry disease (FD) is an X-linked, lysosomal storage disorder leading to severe cardiomyopathy in a significant proportion of patients. To identify ECG markers that reflect early cardiac involvement and disease progression, we conducted a long term retrospective study in a large cohort of FD patients. Methods: A total of 1995 ECGs from 133 patients with classical FD (64% females, 80% treated with enzyme replacement therapy), spanning 20 years of follow-up, were compared to ECGs from 3893 apparently healthy individuals. Generalized linear mixed models were used to evaluate the effect of age, FD and sex on: P-wave duration, PR-interval, QRS-duration, QTc, Cornell index, spatial QRS-T angle and frontal QRS-axis. Regression slopes and absolute values for each parameter were compared between FD patients and control subjects. Results: At a younger age (p p Conclusions: ECG abnormalities indicative of FD are age and sex dependent. Tracking the rate of change in ECG parameters could be a good way to detect disease progression, guiding treatment initiation. Moreover, monitoring ECG changes in FD can be used to evaluate the effectiveness of treatment.

Keywords